Bonmax PTH PEN Device: Innovative Health Monitoring Tool

Description:

• Contains the active component Teriparatide.
• A synthetic version of parathyroid hormone (PTH) produced by the parathyroid glands.
• Used for treating osteoporosis, a condition marked by weakened bones and increased likelihood of fractures.

Uses:

• Postmenopausal osteoporosis.
• Glucocorticoid-induced osteoporosis.

Therapeutic Effects:

• Stimulates the formation of new bone tissue.
• Increases bone mineral density.
• Enhances bone strength.
• Reduces fracture risk.
• Promotes bone healing.

Administration:

• Typically administered by a healthcare professional.
• Usually given as an injection.
• Dosage and duration of treatment determined by healthcare provider.

Contraindications:

• Hypersensitivity or allergic reaction to Bonmax PTH Pen Device or its components.
• History of skeletal malignancies, such as osteosarcoma.
• Bone metastases.
• Prior radiation therapy involving the skeleton.

Safety Advice:

• Pregnancy: The safety of use during pregnancy has not been established.
• Breastfeeding: Consult a doctor while breastfeeding.
• Lungs: Consult healthcare provider if you have a pre-existing lung condition.
• Liver: Consult healthcare provider if you have a liver condition.
• Alcohol: Avoid consuming alcohol while taking the medication.
• Driving: Avoid driving or operating heavy machinery if experiencing side effects such as dizziness or fatigue.

Side Effects:

• Serious: Hypercalcemia, allergic reactions, skin reactions at the injection site, osteosarcoma, orthostatic hypotension.
• Common: Arthralgia, nerve pain, nausea, headache, dizziness, increased sweating, breathlessness, muscle cramps, increase in blood cholesterol levels, chest pain, burning sensation below the breast bone, anaemia.

FAQ:

• Q1. Can Bonmax PTH Pen Device be used in individuals with a history of cancer?

  • Bonmax PTH Pen Device is generally not recommended for individuals with a history of cancer, especially skeletal malignancies or bone metastases.

• Q2. Can Bonmax PTH Pen Device be used in men with osteoporosis?

  • Yes, Bonmax PTH Pen Device can be used in men with osteoporosis.

• Q3. Can Bonmax PTH Pen Device be used in individuals with a history of kidney disease?

  • Bonmax PTH Pen Device can be used in individuals with mild to moderate kidney impairment. Caution is advised in individuals with severe kidney disease.

• Q4. Can Bonmax PTH Pen Device be used in individuals with a history of fractures?

  • Bonmax PTH Pen Device is commonly prescribed for individuals with a history of fragility fractures.

• Q5. Can Bonmax PTH Pen Device be used as a first-line treatment for osteoporosis?

  • Bonmax PTH Pen Device is typically not used as a first-line treatment for osteoporosis.

• Q6. What are the potential long-term effects of the Bonmax PTH Pen Device?

  • The long-term effects of the Bonmax PTH Pen Device have yet to be well understood, particularly beyond the recommended treatment duration of 2 years.

• Q7. What are the side effects of the Bonmax PTH Pen Device?

  • Bonmax PTH Pen Device may cause side effects, including common ones such as injection site reactions, nausea, dizziness, and headache. Serious side effects, though rare, can include the development of osteosarcoma and the potential for hypercalcemia.

Storage:

• Stored at controlled temperature, between 2-8°C.
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep away from children and pets.

Fact Box:

• Molecule name: Teriparatide.
• Therapeutic class: Bone formation stimulator.
• Pharmacological class: Parathyroid hormone analogs.
• Indications: Postmenopausal osteoporosis, glucocorticoid-induced osteoporosis.

Теги: health-device, medical-technology, diagnostic-tool, pth-pen-device, bonmax-device